Top Markets
#1 Siren Siren +33.94%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.71%
#3 Ribbita by Virtuals Ribbita by Virtuals +18.13%
#4 Wiki Cat Wiki Cat +17.37%
#5 PulseChain PulseChain +16.92%
#6 Cysic Cysic +16.47%
#7 Velvet Velvet +16.43%
#8 Bitway Bitway +16.27%
#9 KUB Coin KUB Coin +15.77%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.36%
Coin of the day
Siren Siren
Instellingen
Taal
DUTCH
Valuta
USD
Thema
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Rang in aandelen #31255
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Aandeelprijs
$0.39
Marktkapitalisatie
$13.79M
Verandering (1 dag)
-13.53%
Verandering (1 jaar)
-68.80%
Land
IL
Handel NeuroSense Therapeutics Ltd. (NRSN)

Categorie

Healthcare
Winst voor NeuroSense Therapeutics Ltd. (NRSN)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van NeuroSense Therapeutics Ltd. bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van NeuroSense Therapeutics Ltd. van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE